Trial · NCT05528913
Benralizumab in Chronic Prurigo - Investigating Clinical Efficacy (BICPIC)
NCT05528913, Phase 2, Withdrawn, Charite University, Berlin, Germany
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Benralizumab in Chronic Prurigo - Investigating Clinical Efficacy (BICPIC). Trials, record NCT05528913. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05528913
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Benralizumab in Chronic Prurigo - Investigating Clinical Efficacy (BICPIC)
- NCT number
- NCT05528913
- Status
- Withdrawn
- Phases
- Phase 2
- Enrollment
- 0 participants, actual
- Lead sponsor
- Charite University, Berlin, Germany
- Conditions
- Chronic Prurigo
- Interventions
- Fasenra Prefilled Syringe, Matching Placebo Solution
- First posted
- 2022-09-06
- Last updated
- 2024-01-08
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Numerical rating scale of the worst itch (WI-NRS) | Week 0 to week 12 | Percent change from baseline in numerical rating scale of the worst itch |
| Secondary | Effects on responder rates | 12 weeks | Effects on responder rates at week 4, 8 and 12 (defined by \> 3 point change on WI-NRS) |
| Secondary | Pruritus WI-NRS | 12 weeks | Absolute and Percent change from baseline in weekly average of the maximum pruritus and average pruritus WI-NRS at every week |
| Secondary | Prurigo Activity Score (PAS) | 12 weeks | Change in prurigo activity score (PAS) from baseline to week 4, 8 and 12 |
| Secondary | Prurigo Control Test (PCT) | 12 weeks | Change in the overall disease control, as assessed by the prurigo control test (PCT) from baseline to week 4, 8 and 12 |
| Secondary | Investigator Global Assessment (IGA) | 12 weeks | Change in Investigator Global Assessment (IGA)-activity from baseline to week 4, 8 and 12 |
| Secondary | Investigator Global Assessment (IGA)-stage | 12 weeks | Change in IGA-stage from baseline to week 4, 8 and 12 |
| Secondary | Change in the patient's quality of life | 12 weeks | patient's quality of life assessed by ItchyQoL and Dermatology Life Quality index (DLQI) |
| Secondary | Numerical rating scale (NRS) of sleep disturbance | 12 weeks | Effects on sleep disturbance NRS |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05528913
GET https://conductscience.org/api/trials/v1/NCT05528913/registered